Tyrosine 250 mg
Natural health product licensed in Canada
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 80000464
- Status
- Active licence
- Licence date
- 13 June 2005
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Phosphate de dicalcium dihydrate, Gélatine, Dioxyde de silicium, Stéarate de magnésium végétal, Eau purifiée, cellulose, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | Not specified |
Uses authorised in Canada
Helps in the management of some forms of stress (physical, psychological, sleep depravation, multitasking etc.)
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if pregnant or breast feeding.
- Précautions et mises en garde
Consult a helath care practitioner if you have hyperthyroidism or Graves's Disease. Consult a health care practitioner if you are taking dopamine, levodopa, thyroid medication and/or contraceptive medication. Discontinue use if you experience nausea, headache, fatigue, heartburn or joint pain.
Source
Official Health Canada record, licence 80000464
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.